Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2003
03/06/2003US20030044409 Complexing to epitope; cancer immunotherapy
03/06/2003US20030044406 Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents
03/06/2003US20030044405 Sustained release; drug delivery; tissue adhesive
03/06/2003US20030044398 Transplanting cells
03/06/2003US20030043176 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003CA2494870A1 Methods for inhibiting angiogenesis
03/06/2003CA2459141A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458640A1 Diagnosis, prevention and treatment of cancer
03/06/2003CA2458627A1 Human cdr-grafted antibody and antibody fragment thereof
03/06/2003CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain
03/06/2003CA2458559A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003CA2458445A1 Extracellular messengers
03/06/2003CA2458381A1 Transmembrane protein differentially expressed in cancer
03/06/2003CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003CA2457807A1 Ashbya gossypii enzymes
03/05/2003EP1288661A1 Method for examining wt1-related disease
03/05/2003EP1288301A1 Plant-derived resistance gene
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288298A2 TRNA synthetase from Staphylococcus aureus
03/05/2003EP1288227A1 Coactivator of nuclear receptors
03/05/2003EP1287832A2 Use of leukemia inhibitory factor antagonist
03/05/2003EP1287355A2 Methods and compounds for influencing $g(b)3 integrin-dependent intracellular processes
03/05/2003EP1287161A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
03/05/2003EP1287147A2 Immunotoxin fusion proteins and means for expression thereof
03/05/2003EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
03/05/2003EP1287141A2 Extracellular messengers
03/05/2003EP1287140A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
03/05/2003EP1287138A1 Novel g-protein coupled receptor
03/05/2003EP1287134A2 The human voltage-gated sodium channel beta-1a subunit and methods of use
03/05/2003EP1287132A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/05/2003EP1287131A2 Regulator of g protein signalling (rgs8)
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287123A2 Subtilisin variants
03/05/2003EP1287121A2 Extracellular domain of ryk protein for regulating angiogenesis
03/05/2003EP1287036A1 Trivalent antibody constructs having variable regions that are stabilized by disulfide bridges
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1287032A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/05/2003EP1287031A2 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
03/05/2003EP1287029A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287024A2 Virulence genes, proteins, and their use
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1286698A1 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
03/05/2003EP1286697A2 Method for selectively inhibiting ghrelin action
03/05/2003EP1286692A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
03/05/2003EP1286682A1 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
03/05/2003EP1286677A1 Purified material having size and growth inhibitory effects on cells and tissues
03/05/2003EP1163004B1 Immunoadsorber for use in sepsis therapy
03/05/2003EP1069907A4 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS
03/05/2003EP0932417B1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
03/05/2003EP0877795A4 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
03/05/2003EP0830143B1 Use of leukemia inhibitory factor and endothelin antagonists
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0669913B1 Detection of hypoxia
03/05/2003EP0625157B1 PLATELET GPIIIa P1A1 AND P1A2 EPITOPES, THEIR PREPARATION AND USE
03/05/2003EP0602126B1 Immunoglobulin variants for specific fc epsilon receptors
03/05/2003CN1401003A Gene Sp17 inhibiting lesion formation in plant and utilization thereof
03/05/2003CN1400316A Collapsin reaction medium protein-1
03/05/2003CN1400309A Large wasp sedative peptide precursor gene and its coded polypeptide and preparation method
03/05/2003CN1400222A Monoclonal antibody resisting human small cell lung carcinoma and its application
03/05/2003CN1102660C Antihumanfibrin monoclonal antibody heavy chain and light chain variable region gene and its application
03/04/2003WO2002020614A2 Endoglin-specific polypeptide, production and use thereof
03/04/2003US6528634 Aiolos gene
03/04/2003US6528625 Chemokine Receptor 5 Protein (CCR5 or CKR-5); inhibition of interaction of cell bearing CCR5 with a ligand; inhibiting HIV infection of a cell; use treatment and prevention of HIV
03/04/2003US6528624 Comprising a human IgG Fc region with amino acid substitution at two or more positions; displays altered effector function; C1q binding affinity; complement dependent cytotoxicity
03/04/2003US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand
03/04/2003US6528493 Modulating activity of endogenous protein
03/04/2003US6528482 Receptor activator of NF-κB
03/04/2003US6528303 Neuropeptide Y-Y5 receptor
03/04/2003US6528297 Human lysozyme gene, its encoded polypeptide and the method for preparing them
03/04/2003US6528294 To effect protein phosphorylation; for use in diagnosis and therapy
03/04/2003US6528284 S-Region Transfer Activity-70 (SRTA-70); can be used as therapeutic agents in immune response modulation
03/04/2003US6528269 Monoclonal antibodies; can be used to diagnose neurodegenerative disorders
03/04/2003US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer
03/04/2003US6528061 purified immunogenic polypeptide comprising a polysaccharide mimotope recognized by a protective monoclonal antibody having a specificity for a surface polysaccharide of a bacterium of the Shigella species, said surface polysaccharide
03/04/2003US6528060 Therapeutic compounds
03/04/2003US6528057 Method for removal of HIV and other viruses from blood
03/04/2003US6528056 Inhibition of viral infection using antigen-binding proteins
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/04/2003US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast
03/04/2003US6528051 Targeted delivery system comprising at least one component-specific immunostimulating molecule bound to a platform.
03/04/2003US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting
03/04/2003CA2421202A1 Endoglin-specific polypeptide, production and use thereof
03/04/2003CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
02/2003
02/28/2003CA2400531A1 Human nhe2
02/27/2003WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof
02/27/2003WO2003016913A1 Suppression of cross-reactivity and non-specific binding by antibodies using protein a
02/27/2003WO2003016907A1 Reagent for assaying laminin 5 antigen in biological sample and assay method
02/27/2003WO2003016906A1 Method of diagnosing or monitoring saccharometabolic error
02/27/2003WO2003016904A2 Peptide sequence tags and method of using same
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016535A2 Novel amylases and uses thereof
02/27/2003WO2003016529A1 Novel blomia tropicalis antigens and uses therefor
02/27/2003WO2003016506A2 Secreted proteins
02/27/2003WO2003016501A2 Recombinant antibodies, and compositions and methods for making and using the same
1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 1494